Trial intelligence / Profile preview

INSPIRED HCV: Pioglitazone for Insulin Resistant Hepatitis C

NCT00433069Phase 2Completed

Start
Jan 2007
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pioglitazone in hepatitis C (HCV). Started Jan 2007; status: completed.

02

Drugs

pioglitazone
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00433069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00433069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call